134 related articles for article (PubMed ID: 17633068)
1. The role of neoadjuvant chemotherapy versus primary surgery in the management of stage III ovarian cancer.
Van Gorp T; Amant F; Neven P; Berteloot P; Leunen K; Vergote I
Cancer Treat Res; 2007; 134():387-402. PubMed ID: 17633068
[No Abstract] [Full Text] [Related]
2. The role of minimally invasive interval debulking surgery in advanced epithelial ovarian cancer.
Menderes G; Black JD; Azodi M
Expert Rev Anticancer Ther; 2016 Sep; 16(9):899-901. PubMed ID: 27477495
[No Abstract] [Full Text] [Related]
3. Indications for minimally invasive surgery for ovarian cancer.
Han ES; Wakabayashi M
J Natl Compr Canc Netw; 2011 Jan; 9(1):126-32. PubMed ID: 21233249
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant chemotherapy versus primary debulking surgery in advanced ovarian cancer.
Vergote IB; De Wever I; Decloedt J; Tjalma W; Van Gramberen M; van Dam P
Semin Oncol; 2000 Jun; 27(3 Suppl 7):31-6. PubMed ID: 10952124
[TBL] [Abstract][Full Text] [Related]
5. [PRIMARY CYTOREDUCTIVE SURGERY VERSUS NEOADJUVANT CHEMOTHERARY IN TREATMENT OF ADVANCED OVARIAN CANCER (STAGE III C-IV). OUR AND FOREIGN EXPERIENCE].
Ivanov S; Kovachev E; Kolev N; Bechev B; Kolev N
Akush Ginekol (Sofiia); 2016; 55 Suppl 1 Pt 1():16-9. PubMed ID: 27514164
[TBL] [Abstract][Full Text] [Related]
6. Current Recommendations for Minimally Invasive Surgical Staging in Ovarian Cancer.
Fagotti A; Perelli F; Pedone L; Scambia G
Curr Treat Options Oncol; 2016 Jan; 17(1):3. PubMed ID: 26739150
[TBL] [Abstract][Full Text] [Related]
7. Role of minimally invasive surgery in ovarian cancer.
Nezhat FR; Pejovic T; Finger TN; Khalil SS
J Minim Invasive Gynecol; 2013; 20(6):754-65. PubMed ID: 24183269
[TBL] [Abstract][Full Text] [Related]
8. Value of Neoadjuvant Chemotherapy for Newly Diagnosed Advanced Ovarian Cancer: A European Perspective.
Fotopoulou C; Sehouli J; Aletti G; Harter P; Mahner S; Querleu D; Chiva L; Gabra H; Colombo N; du Bois A
J Clin Oncol; 2017 Feb; 35(6):587-590. PubMed ID: 28068169
[No Abstract] [Full Text] [Related]
9. Minimally Invasive Surgical Staging in Early-stage Ovarian Carcinoma: A Systematic Review and Meta-analysis.
Bogani G; Borghi C; Leone Roberti Maggiore U; Ditto A; Signorelli M; Martinelli F; Chiappa V; Lopez C; Sabatucci I; Scaffa C; Indini A; Ferrero S; Lorusso D; Raspagliesi F
J Minim Invasive Gynecol; 2017; 24(4):552-562. PubMed ID: 28223182
[TBL] [Abstract][Full Text] [Related]
10. Surgical management of epithelial ovarian cancer.
Salani R; Bristow RE
Clin Obstet Gynecol; 2012 Mar; 55(1):75-95. PubMed ID: 22343231
[TBL] [Abstract][Full Text] [Related]
11. Timing of debulking surgery in advanced ovarian cancer.
Vergote I; van Gorp T; Amant F; Leunen K; Neven P; Berteloot P
Int J Gynecol Cancer; 2008; 18 Suppl 1():11-9. PubMed ID: 18336393
[TBL] [Abstract][Full Text] [Related]
12. A Comparison of Survival Outcomes in Advanced Serous Ovarian Cancer Patients Treated With Primary Debulking Surgery Versus Neoadjuvant Chemotherapy.
May T; Comeau R; Sun P; Kotsopoulos J; Narod SA; Rosen B; Ghatage P
Int J Gynecol Cancer; 2017 May; 27(4):668-674. PubMed ID: 28441250
[TBL] [Abstract][Full Text] [Related]
13. Minimally invasive interval debulking surgery in ovarian neoplasm (MISSION trial-NCT02324595): a feasibility study.
Gueli Alletti S; Bottoni C; Fanfani F; Gallotta V; Chiantera V; Costantini B; Cosentino F; Ercoli A; Scambia G; Fagotti A
Am J Obstet Gynecol; 2016 Apr; 214(4):503.e1-503.e6. PubMed ID: 26529370
[TBL] [Abstract][Full Text] [Related]
14. [Advanced ovarian cancer: primary debulking (PDS) or neoadjuvant chemotherapy (NACT) - still a debate].
Segev Y; Gemer O; Auslender R; Lavie O
Harefuah; 2014 Sep; 153(9):527-31, 558. PubMed ID: 25417489
[TBL] [Abstract][Full Text] [Related]
15. Video-assisted thoracic surgery (VATS) evaluation of intrathoracic disease in patients with FIGO III and IV stage ovarian cancer.
Klar M; Farthmann J; Bossart M; Stremmel C; Gitsch G; Passlick B; Pache G; Woll J; Hasenburg A
Gynecol Oncol; 2012 Sep; 126(3):397-402. PubMed ID: 22613353
[TBL] [Abstract][Full Text] [Related]
16. The impacts of neoadjuvant chemotherapy and of debulking surgery on survival from advanced ovarian cancer.
Rosen B; Laframboise S; Ferguson S; Dodge J; Bernardini M; Murphy J; Segev Y; Sun P; Narod SA
Gynecol Oncol; 2014 Sep; 134(3):462-7. PubMed ID: 25026637
[TBL] [Abstract][Full Text] [Related]
17. The role of neoadjuvant chemotherapy in treating advanced epithelial ovarian cancer.
Weinberg LE; Rodriguez G; Hurteau JA
J Surg Oncol; 2010 Mar; 101(4):334-43. PubMed ID: 20187069
[TBL] [Abstract][Full Text] [Related]
18. Serous ovarian and primary peritoneal cancers: A comparative analysis of clinico-pathological features, molecular subtypes and treatment outcome.
Gao B; Lindemann K; Anderson L; Fereday S; Hung J; Alsop K; Tothill RW; Gebski V; Kennedy C; Balleine RL; ; Harnett PR; Bowtell DD; DeFazio A
Gynecol Oncol; 2016 Sep; 142(3):458-64. PubMed ID: 27444035
[TBL] [Abstract][Full Text] [Related]
19. Oncologic Concerns regarding Laparoscopic Cytoreductive Surgery in Patients with Advanced Ovarian Cancer Submitted to Neoadjuvant Chemotherapy.
Favero G; Macerox N; Pfiffer T; Köhler C; da Costa Miranda V; Estevez Diz Mdel P; Fukushima JT; Baracat EC; Carvalho JP
Oncology; 2015; 89(3):159-66. PubMed ID: 25968072
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant chemotherapy and primary debulking surgery utilization for advanced-stage ovarian cancer at a comprehensive cancer center.
Mueller JJ; Zhou QC; Iasonos A; O'Cearbhaill RE; Alvi FA; El Haraki A; Eriksson AG; Gardner GJ; Sonoda Y; Levine DA; Aghajanian C; Chi DS; Abu-Rustum NR; Zivanovic O
Gynecol Oncol; 2016 Mar; 140(3):436-42. PubMed ID: 26777991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
